COGNEX CORP CGNX
Nasdaq · XNAS · stock · Industrial Instruments For Measurement, Display, and Control
Chart by TradingView
7/9
Piotroski F — financial health
5.86
Altman Z″ — distress risk · safe
47.7%
Dividend payout · moderate
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $994.4M | $114.4M | $665.4M | $236.8M | $1.5B |
| 2024 | $914.5M | $106.2M | $625.8M | $134.0M | $1.5B |
| 2023 | $837.5M | $113.2M | $601.2M | $89.8M | $1.5B |
| 2022 | $1.0B | $215.5M | $721.9M | $223.7M | $1.4B |
| 2021 | $1.0B | $279.9M | $759.8M | $298.6M | $1.4B |
| 2020 | $811.0M | $176.2M | $604.6M | $229.1M | $1.3B |
Why these scores methodology →
Piotroski F-score: 7/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 5.86 (safe)
- Working capital / assets 0.255
- Retained earnings / assets 0.202
- EBIT / assets 0.081
- Equity / liabilities 2.844
Source: SEC EDGAR filings · CIK 0000851205 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.